References
- Bansal K, Liang ML, Rutka JT (2006). Molecular biology of human gliomas. Technol Cancer Res Treat, 5, 185-94. https://doi.org/10.1177/153303460600500302
- Feng B, Hu P, Lu SJ, et al (2014). Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis. Asian Pac J Cancer Prev, 15, 4079-83. https://doi.org/10.7314/APJCP.2014.15.9.4079
- Hollier BG, Tinnirello AA, Werden SJ, et al (2013). FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res, 73, 1981-92. https://doi.org/10.1158/0008-5472.CAN-12-2962
- Jiang W, Pang XG, Wang Q, et al (2012). Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin Lung Cancer, 13, 280-7. https://doi.org/10.1016/j.cllc.2011.11.005
- Kume T (2008). Foxc2 transcription factor: a newly described regulator of angiogenesis. Trends Cardiovasc Med, 18, 224-8. https://doi.org/10.1016/j.tcm.2008.11.003
- Kume T (2012). The role of FoxC2 transcription factor in tumor angiogenesis. J Oncol, 2012, 204593.
- Li W, Fu X, Liu R, et al (2013). FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Oncol Res, 21, 111-20.
- Liu B, Han SM, Tang XY, et al (2014). Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Oncol Rep, 31, 2545-54.
- Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
- Mani SA, Yang J, Brooks M, et al (2007). Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA, 104, 10069-74. https://doi.org/10.1073/pnas.0703900104
- Meyer MA (2008). Malignant gliomas in adults. N Engl J Med, 359, 1850.
- Nishida N, Mimori K, Yokobori T, et al (2011). FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol, 18, 535-42. https://doi.org/10.1245/s10434-010-1274-y
- Reni M, Mazza E, Tosoni A, et al (2005). Novel therapeutics in adult malignant brain gliomas. Expert Opin Investig Drugs, 14, 643-58. https://doi.org/10.1517/13543784.14.6.643
- Van Meir EG, Hadjipanayis CG, Norden AD, et al (2010). Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin, 60, 166-93. https://doi.org/10.3322/caac.20069
- Watanabe T, Kobunai T, Yamamoto Y, et al (2011). Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. Int Surg, 96, 207-16. https://doi.org/10.9738/1399.1
- Wu X, Liu NF (2011). FOXC2 transcription factor: a novel regulator of lymphangiogenesis. Lymphology, 44, 35-41.
- Zheng CH, Quan Y, Li YY, et al (2014). Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation. Asian Pac J Cancer Prev, 15, 1589-95. https://doi.org/10.7314/APJCP.2014.15.4.1589
- Zhu JL, Song YX, Wang ZN, et al (2013). The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma. Histopathology, 62, 1038-48. https://doi.org/10.1111/his.12132
Cited by
- Preoperative Grading of Astrocytic Supratentorial Brain Tumors with Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient vol.13, pp.3, 2016, https://doi.org/10.5812/iranjradiol.30426
- Induction of epithelial to mesenchymal transition (EMT) and inhibition on adipogenesis: Two different sides of the same coin? Feasible roles and mechanisms of transforming growth factor β1 (TGF-β1) in age-related thymic involution vol.40, pp.8, 2016, https://doi.org/10.1002/cbin.10625
- Detection of microRNA-200b may predict the inhibitory effect of gefitinib on non-small cell lung cancer and its potential mechanism vol.12, pp.6, 2016, https://doi.org/10.3892/ol.2016.5365
- A Forkhead Box Protein C2 Inhibitor: Targeting Epithelial-Mesenchymal Transition and Cancer Metastasis vol.19, pp.13, 2018, https://doi.org/10.1002/cbic.201800022